ArticleTrials2025
Medical benefits of telerehabilitation with Orthelligent HOME® after anterior cruciate ligament (ACL) reconstruction: study protocol for a randomised controlled trial - the ORSOME-II study.
Article in Trials, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDigital technologies are increasingly being integrated into home-based telerehabilitation programmes for orthopaedic indications. Generally, patient-individualised and rehabilitation progress-specific adaptations can support early rehabilitation after knee surgery for anterior cruciate ligament reconstruction (ACL-R). The designed study will evaluate the medical benefit of a digital telerehabilitation system in addition to standard physiotherapy during the early rehabilitation phase.
methodsIn a prospective, randomised controlled, single-blinded multicenter trial, 204 patients with a planned ACL-R (male/female, age 14-65 years) will be recruited and randomly assigned to either a control group (physiotherapy, standard of care) or the intervention group to use the telerehabilitation system Orthelligent HOME® in addition to standard of care after surgery. As prespecified objectifiable primary outcome, knee function and stability will be assessed 9 weeks postoperatively by single-leg vertical jump. Jump height and jump quality will be measured using the My Jump app and an evaluation matrix to quantify defined pre stages of the vertical jump performance. Subjective knee function (IKDC-SKF) and knee-related quality of life (KOOS) will be assessed as secondary outcomes. Additionally, return-to-sports (ACL-RSI), return-to-work, and non-sport-based knee-related everyday function (LERAS-13) as well as use of therapeutic appliances and aids will be quantified. All patients will be followed up for 52 weeks. DISCUSSION: This protocol seeks to determine the medical benefit of a digital rehabilitation tool in enhancing ACL recovery outcomes, potentially addressing the rehabilitation gap often experienced by patients following supervised physical therapy. It aims to provide information on the potential of using digital rehabilitation devices as a supplement to standard physiotherapy for early rehabilitation after ACL-R.
trial registrationGerman Clinical Trials Register (DRKS): DRKS00031465 (registration date: 10.07.2023, prospectively registered).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.